Public Groupactive 16 hours, 20 minutes ago
This group unites PH patients, caregivers, researchers and medical professionals in a platform to discuss the latest research and medical advances related to pulmonary hypertension. Information shared in this group is public.
Ralinepag Reduces PAH Patients’ Risk of Death, Phase 2 Trial Shows
- This topic has 1 voice and 0 replies.
- You must be logged in to reply to this topic.